Breast Cancer Polygenic Risk Score Can Help Predict Risk of Contralateral Disease

Feb

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

In this session, the second in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review cases in which patient genomic profiles exhibit common driver mutations in tumor types considered “off label” for targeted therapies associated with those mutations.

Mar

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Menu

Breast Cancer Polygenic Risk Score Can Help Predict Risk of Contralateral Disease

To read the full story....

Breaking News

Guardant Health Q4 Revenues Up 25 Percent

Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

CareDx Q4 Revenues Up 64 Percent

Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test

Proteogenomic Study Expands Catalog of Cell Cycle Players

Recent Headlines from
Precision Oncology News

CAR T-Cell Resistance Mechanism Shows Need for Multi-Antigen Targeted Immunotherapy Strategies

Benefit of AstraZeneca's Cediranib Plus Lynparza May Be Limited to HRR-Deficient Prostate Cancers

Fecal Transplants Boost Immunotherapy Response in Subset of Melanoma Patients

Strata Oncology Launches Large Study Eyeing Competitive Cancer Monitoring, Drug Selection Test Space

With First-In-Class Iovance BLA Pending, TIL Therapies on Cusp of Commercialization

Featured White Papers

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

What's Popular?

Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test

Adaptive Biotechnologies, LabCorp Expand Collaboration

AnchorDx Closes $40M Series C Financing Round

AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

Sponsorships